<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05037604</url>
  </required_header>
  <id_info>
    <org_study_id>FactorsDermatoporosis</org_study_id>
    <nct_id>NCT05037604</nct_id>
  </id_info>
  <brief_title>Factors Associated With Dermatoporosis</brief_title>
  <acronym>FAWD</acronym>
  <official_title>Factors Associated With Dermatoporosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Autonoma de San Luis Potosí</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Autonoma de San Luis Potosí</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dermatoporosis is a chronic syndrome of skin insufficiency or fragility. It is characterized&#xD;
      by cutaneous atrophy, senile purpura and stellate pseudoscars. Dermatoporosis prevalence is&#xD;
      37% in ≥65 years.&#xD;
&#xD;
      The objective was to determine factors associated with this diagnosis in &gt;60 years old&#xD;
      patients of the outpatient clinic in the Hospital Central &quot;Dr. Ignacio Morones Prieto &quot; San&#xD;
      Luis Potosí, México.&#xD;
&#xD;
      An observational, cross-sectional, descriptive, and analytical study was performed. Patients&#xD;
      &gt;60 years old were selected. A clinical history, clinical examination, and application of a&#xD;
      validated diagnostic self-questionnaire were performed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dermatoporosis is a chronic syndrome of skin insufficiency or fragility. It is characterized&#xD;
      by cutaneous atrophy, senile purpura and stellate pseudoscars. Dermatoporosis prevalence is&#xD;
      37% in ≥65 years.The objective was to determine factors associated with this diagnosis in &gt;60&#xD;
      years old patients of the outpatient clinic in the Hospital Central &quot;Dr. Ignacio Morones&#xD;
      Prieto &quot; San Luis Potosí, México.&#xD;
&#xD;
      An observational, cross-sectional, descriptive and analytical study was performed. Through&#xD;
      consecutive non-probabilistic sampling, patients &gt; 60 years old were selected, who underwent&#xD;
      a clinical history, clinical examination, and the application of a validated diagnostic&#xD;
      self-questionnaire. To determine the association of the factors, a multivariate logistic&#xD;
      regression analysis, it will be used the PRIMERv6 software with the PERMANOVA package. A p&#xD;
      &lt;0.05 was considered significant. The normality of the distribution of the continuous&#xD;
      variables was evaluated with the Shapiro Wilk test. The Student's t test was performed on&#xD;
      variables that met the homogeneity of variance requirements. In the variables that did not&#xD;
      meet this criterion, a non-parametric analysis was performed with the Mann U Whitney test.&#xD;
      For the analysis of categorical variables, Fisher's exact test or chi-square test was used.&#xD;
      Continuous variables were reported by mean (median) [Q1, Q3] (min - max) and by standard&#xD;
      deviations as their distribution corresponds. Nominal categorical variables were expressed as&#xD;
      frequencies&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Actual">April 30, 2019</completion_date>
  <primary_completion_date type="Actual">November 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Factors associated with Dermatoporosis</measure>
    <time_frame>At time of enrollment</time_frame>
    <description>Presence of factors related to age, sex, personal history of diseases, chronic oral treatments, gyneco-obstetrics background, chronic photoexposure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diagnostic by self assesment tool</measure>
    <time_frame>At time of enrollment</time_frame>
    <description>Diagnostic of dermatoporosis made by self assesment tool</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physical examination</measure>
    <time_frame>At time of enrollment</time_frame>
    <description>Presence of pseudoscars (stellate scars) in the physical examination</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">315</enrollment>
  <condition>Senile Purpura</condition>
  <arm_group>
    <arm_group_label>Cases</arm_group_label>
    <description>Patients diagnosed with dermatoporosis. A clinical history, physical examination, and application of a previously validated diagnostic self-questionnaire were performed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Patients not diagnosed with dermatoporosis. A clinical history, physical examination, and application of a previously validated diagnostic self-questionnaire were performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire about associated factors</intervention_name>
    <description>Questionnaire about age, prolonged sun exposure, intake of anticoagulants / antiplatelets, intake of oral steroids, chronic kidney disease. Maternal age&gt; 40 years in their last child , time of lactation per pregnancy and cumulative time of lactation. Age of the first pregnancy and age of menopause onset.</description>
    <arm_group_label>Cases</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Self questionnaire diagnostic tool</intervention_name>
    <description>Self questionnaire of physical characteristics</description>
    <arm_group_label>Cases</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical Examination</intervention_name>
    <description>Physical Examination made by a dermatologist</description>
    <arm_group_label>Cases</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients over 60 years of age who attended the outpatient clinic of the Hospital Central&#xD;
        &quot;Dr. Ignacio Morones Prieto &quot;&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients over 60 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients in whom physical examination cannot be performed due to the use of orthopedic&#xD;
             devices such as splints, bandages, etc.&#xD;
&#xD;
          -  Patients with whom interviewer-patient verbal communication is difficult due to some&#xD;
             hearing or neurological deficit.&#xD;
&#xD;
          -  Patients with neurological, psychiatric disorders who are unable to provide reliable&#xD;
             information. (disorganized, incoherent speech, cognitive deficit)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan Pablo Castanedo-Cazares, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Autonoma de San Luis Potosí</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Central &quot;Dr. Ignacio Morones Prieto&quot;</name>
      <address>
        <city>San Luis Potosi</city>
        <zip>78220</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <link>
    <url>https://www.inegi.org.mx/contenidos/productos/prod_serv/contenidos/espanol/bvinegi/productos/nueva_estruc/AEGEUM_2018/702825107000.pdf</url>
    <description>INEGI. Población. Censos y conteos Población y Vivienda</description>
  </link>
  <link>
    <url>http://www.diputados.gob.mx/sedia/sia/spi/SAPI-ISS-11-17.pdf</url>
    <description>ADULTOS MAYORES Análisis Integral de su Situación Jurídica en México</description>
  </link>
  <link>
    <url>https://doi.org/10.1002/ddr.20137</url>
    <description>The metabolic syndrome: linking oxidative stress and inflammation to obesity, type 2 diabetes, and the syndrome</description>
  </link>
  <link>
    <url>https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=35548</url>
    <description>Estimación del tiempo de exposición solar para quemadura en población mexicana.</description>
  </link>
  <link>
    <url>https://www.inegi.org.mx/contenidos/productos/prod_serv/contenidos/espanol/bvinegi/productos/nueva_estruc/AEGEUM_2018/702825107000.pdf</url>
    <description>INEGI. Encuesta Intercensal 2015</description>
  </link>
  <results_reference>
    <citation>Kaya G, Kaya A, Sorg O, Saurat JH. Dermatoporosis: a further step to recognition. J Eur Acad Dermatol Venereol. 2018 Feb;32(2):189-191. doi: 10.1111/jdv.14777.</citation>
    <PMID>29465833</PMID>
  </results_reference>
  <results_reference>
    <citation>Han A, Chien AL, Kang S. Photoaging. Dermatol Clin. 2014 Jul;32(3):291-9, vii. doi: 10.1016/j.det.2014.03.015. Review.</citation>
    <PMID>24891052</PMID>
  </results_reference>
  <results_reference>
    <citation>Kaya G, Saurat JH. Dermatoporosis: a chronic cutaneous insufficiency/fragility syndrome. Clinicopathological features, mechanisms, prevention and potential treatments. Dermatology. 2007;215(4):284-94. Review.</citation>
    <PMID>17911985</PMID>
  </results_reference>
  <results_reference>
    <citation>Kluger N, Impivaara S. Prevalence of and risk factors for dermatoporosis: a prospective observational study of dermatology outpatients in a Finnish tertiary care hospital. J Eur Acad Dermatol Venereol. 2019 Feb;33(2):447-450. doi: 10.1111/jdv.15240. Epub 2018 Oct 1.</citation>
    <PMID>30198583</PMID>
  </results_reference>
  <results_reference>
    <citation>Vanzi V, Toma E. Recognising and managing age-related dermatoporosis and skin tears. Nurs Older People. 2018 Mar 23;30(3):26-31. doi: 10.7748/nop.2018.e1022.</citation>
    <PMID>29569862</PMID>
  </results_reference>
  <results_reference>
    <citation>Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL. Oxidative Stress in Atherosclerosis. Curr Atheroscler Rep. 2017 Sep 18;19(11):42. doi: 10.1007/s11883-017-0678-6. Review.</citation>
    <PMID>28921056</PMID>
  </results_reference>
  <results_reference>
    <citation>Rapa SF, Di Iorio BR, Campiglia P, Heidland A, Marzocco S. Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites. Int J Mol Sci. 2019 Dec 30;21(1). pii: E263. doi: 10.3390/ijms21010263. Review.</citation>
    <PMID>31906008</PMID>
  </results_reference>
  <results_reference>
    <citation>Gilchrest BA, Blog FB, Szabo G. Effects of aging and chronic sun exposure on melanocytes in human skin. J Invest Dermatol. 1979 Aug;73(2):141-3.</citation>
    <PMID>88488</PMID>
  </results_reference>
  <results_reference>
    <citation>Dekel N, Gnainsky Y, Granot I, Mor G. Inflammation and implantation. Am J Reprod Immunol. 2010 Jan;63(1):17-21. doi: 10.1111/j.1600-0897.2009.00792.x. Review.</citation>
    <PMID>20059465</PMID>
  </results_reference>
  <results_reference>
    <citation>Mor G. Inflammation and pregnancy: the role of toll-like receptors in trophoblast-immune interaction. Ann N Y Acad Sci. 2008 Apr;1127:121-8. doi: 10.1196/annals.1434.006. Review.</citation>
    <PMID>18443339</PMID>
  </results_reference>
  <results_reference>
    <citation>Michaud M, Balardy L, Moulis G, Gaudin C, Peyrot C, Vellas B, Cesari M, Nourhashemi F. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc. 2013 Dec;14(12):877-82. doi: 10.1016/j.jamda.2013.05.009. Epub 2013 Jun 20. Review.</citation>
    <PMID>23792036</PMID>
  </results_reference>
  <results_reference>
    <citation>Straub RH, Schradin C. Chronic inflammatory systemic diseases: An evolutionary trade-off between acutely beneficial but chronically harmful programs. Evol Med Public Health. 2016 Jan 27;2016(1):37-51. doi: 10.1093/emph/eow001. Review.</citation>
    <PMID>26817483</PMID>
  </results_reference>
  <results_reference>
    <citation>Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438. doi: 10.1155/2014/360438. Epub 2014 May 8. Review.</citation>
    <PMID>24999379</PMID>
  </results_reference>
  <results_reference>
    <citation>Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012 Jan;5(1):9-19. doi: 10.1097/WOX.0b013e3182439613. Epub 2012 Jan 13.</citation>
    <PMID>23268465</PMID>
  </results_reference>
  <results_reference>
    <citation>Epel ES, Lithgow GJ. Stress biology and aging mechanisms: toward understanding the deep connection between adaptation to stress and longevity. J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S10-6. doi: 10.1093/gerona/glu055. Review.</citation>
    <PMID>24833580</PMID>
  </results_reference>
  <results_reference>
    <citation>Butte NF, Hopkinson JM, Mehta N, Moon JK, Smith EO. Adjustments in energy expenditure and substrate utilization during late pregnancy and lactation. Am J Clin Nutr. 1999 Feb;69(2):299-307.</citation>
    <PMID>9989696</PMID>
  </results_reference>
  <results_reference>
    <citation>Mengeaud V, Dautezac-Vieu C, Josse G, Vellas B, Schmitt AM. Prevalence of dermatoporosis in elderly French hospital in-patients: a cross-sectional study. Br J Dermatol. 2012 Feb;166(2):442-3. doi: 10.1111/j.1365-2133.2011.10534.x. Epub 2011 Dec 5.</citation>
    <PMID>21787367</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 23, 2021</study_first_submitted>
  <study_first_submitted_qc>August 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 8, 2021</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Autonoma de San Luis Potosí</investigator_affiliation>
    <investigator_full_name>Juan Pablo Castanedo-Cazares</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>dermatoporosis</keyword>
  <keyword>senile</keyword>
  <keyword>purpura</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Purpura</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Database of 315 patients diagnosed and not diagnosed with dermatoporosis will be shared for 3 years. It includes associated factors, physical examination and results of self assesment tool.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>3 years</ipd_time_frame>
    <ipd_access_criteria>The database will be shared with researchers who require it by means of a letter sent to the principle investigator justifying its use for research and attaching a letter that describes the privacy policy to safeguard the information contained in the database.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

